2m 2m 2m 2m 2m 2m 2m
XERIS BIPH HLDG (XERS)
NASDAQ
$8.17+$0.01 (+0.17%)
Price as of Jul 14, 2026 5:12 AM EDT- $1.4BMarket Cap
- 50.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
XERIS BIPH HLDG (XERS)
$8.17+$0.01 (+0.17%)
XERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.16 | ||
Change | -$0.18 (-2.16%) | ||
Open | $8.35 | ||
High | $8.35 | ||
Low | $8.05 | ||
Previous Close | $8.34 | ||
Volume | 1,471,888 | ||
30-Day Average Volume | 2,452,179 | ||
1-Week Change | -2.51% | ||
1-Month Change | 20.18% | ||
1-Year Change | 50.00% | ||
3-Year Change | 221.26% | ||
5-Year Change | 122.34% | ||
Fundamentals | |||
Shares Outstanding | 172.6M | ||
Total Assets | $392.0M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $82.5M | ||
Net Income | $2.2M | ||
Free Cash Flow | $10.2M | ||
EBIT | $2.2M | ||
EBITDA | $4.9M | ||
Net Working Capital | $133.1M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | 307 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 108 | ||
P/E | 816 | ||
PEG | -10 | ||
Price/Free Cash Flow | 138 | ||
Price/Operating Cash Flow | 143 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue